STAT3 and systemic inflammatory response syndrome: In fact, several lines of evidence suggested that inhibition of IL‐6/STAT3 pathway exerts protective effects against LPS‐induced ALI, implying that IL‐6R‐targeted therapy is an effective strategy to alleviate ALI in SIRS.52, 53